Ren S, Xu C, Cui Z, Yu Y, Xu W, Wang F, Lu J, Wei M, Lu X, Gao X et al..  2012.  Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer.. J Mol Med (Berl). 90(10):1121-32.